Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tumor cell lipid bilayer in a hypoxic microenvironment represents a complex structural target defined by its unique physical and chemical properties. In solid tumors, inadequate oxygen supply (hypoxia) forces a shift toward anaerobic glycolysis, resulting in the accumulation of lactic acid and a significantly acidified extracellular environment (pH 6.5–6.8). This acidity, combined with hypoxia-induced changes in lipid metabolism, alters the bilayer's composition, including the externalization of phosphatidylserine and changes in membrane fluidity (Anderson et al., 2016, Cancer Research). These features distinguish the tumor membrane from that of healthy cells, which maintain a physiological pH of approximately 7.4. Therapeutically, this environment is exploited to achieve high selectivity for drug delivery and imaging. The most prominent approach involves pH-Low Insertion Peptides (pHLIPs), which remain unstructured at neutral pH but form an alpha-helix that inserts into the lipid bilayer when the pH drops, effectively tethering cargo to or translocating it into the tumor cell (Wyatt et al., 2017, Trends in Biotechnology). Other strategies include using hypoxia-activated prodrugs or lipid-binding proteins that recognize the altered symmetry of the hypoxic bilayer. This target is considered 'incorrect' in a classical sense because it is a physiological state and cellular structure rather than a single protein or enzyme, yet it serves as a critical focal point for next-generation precision oncology.
Drugs targeting this structure typically utilize the acidic extracellular pH (pHe) or specific lipid alterations (e.g., phosphatidylserine exposure) characteristic of hypoxic environments to trigger membrane insertion, pore formation, or selective binding. For example, pHLIP peptides undergo a pH-dependent conformational change that allows them to insert across the lipid bilayer only in acidic/hypoxic conditions (Reshetnyak et al., 2006, PNAS).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor cell lipid bilayer in hypoxic tumor microenvironment (TCLB-HTM).